HDAC7 and neoplasm: Recent researches revealed that oncogenic actions of HDAC7 are dependent on the c-Myc amplification [18, 32], since c-Myc helps tumor cells escape from cellular senescence process and promotes tumor cell growth via inhibiting p21/p27 expression thus accelerating G1–S cell cycle transition [18, 30].